Ard Tijsterman, MScChief Executive Officer at Biosana Pharma BV
Biotechnologist and entrepreneur with more than 30 years of experience in drug development, bioprocessing and project management. Former Head of Manufacturing & PD at Chiron Corp. Co-founder and former MD of Xendo (CMC/RA consultancy & phase I unit with 250 staff, sold to PPG & QPS) and Tarpon Biosystems (continuous chromatography, sold to Pall Corporation). Currently CEO of BiosanaPharma, a Dutch/Australian company. Biosanapharma focusses on: 3C continuous manufacturing of mAbs, Super Critical CO2 spray drying for large protein formulation and delivery (e.g. mAbs) and product development (biosimilars & biohybrids).